Financial Results

Dr. Reddy’s Q1 FY20 Financial Results

Hyderabad, July 29, 2019: Dr. Reddy's Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated…

5 years ago

Jubilant Life Sciences – Q1’FY20 Results

  Revenue at Rs. 2,182 Crore up 5% YoY; EBITDA at Rs 444 Crores down 1% YoY PAT at Rs 185…

5 years ago

Piramal’s Pharma business grows over 10 % to 4,786 Crore in FY19

 The margins have improved from 10% in FY2011 to 23% in FY2019 Growth is attributed to revenues derived from niche…

5 years ago

HealthCare Global Enterprises Ltd. reports Q4 and FY19 results

Revenue for Q4 FY19 of INR 2,579 Million, a growth of 16% (y-o-y) and for FY19 of INR 9,787 Million,…

6 years ago

Jubilant Life Sciences – Q4 & 12M’FY19 Results

  JUBILANT REPORTS RECORD PERFORMANCE IN FY'19 Revenue up 21% YoY to Rs. 9,111 Crore; EBITDA up 14% YoY to Rs 1,775…

6 years ago

Caredose registers 425% growth in the last quarter of FY 2018-19

To expand its services to five more cities apart from Delhi-NCR Targets expansion in South East Asia, Africa and Middle…

6 years ago

Dr. Reddy’s Q3 FY19 Financial Results

Hyderabad, February 02, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY |NYSE: RDY) today announced its consolidated financial…

6 years ago

Following a solid third quarter, LANXESS confirms its earnings forecast for 2018

Sales increased by 4.4 percent to EUR 1.79 billion in the third quarter EBITDA pre exceptionals 1.5 percent higher at…

6 years ago

ICRA: Hospital sector continues to be under weather in Q2 FY2019

Operating margin drops from 15.0% in Q2 FY2018 to 13.3% In Q2 FY2019 Structurally, in the long term, underlying fundamentals…

6 years ago

Kilitch Drugs (India) records a robust growth in Q2FY19

Net Sales up (YoY) to Rs. 26.72 crore Registers a net profit of Rs.4.49 crore EPS for the second quarter…

6 years ago